Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Ended earlyNCT02874430What this trial is testingMetformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine CancerWho this might be right forBreast CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Early research (Phase 1)Looking for participantsNCT05542407What this trial is testingONC201 and Atezolizumab in Obesity-Driven Endometrial CancerWho this might be right forEndometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more UNC Lineberger Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01935934What this trial is testingCabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more National Cancer Institute (NCI) 102
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Large-scale testing (Phase 3)Looking for participantsNCT05256225What this trial is testingTesting the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaWho this might be right forEndometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+5 more National Cancer Institute (NCI) 360
Very early researchWithdrawnNCT05289648What this trial is testingNiraparib in High-grade Endometrial Cancer TrialWho this might be right forEndometrial CancerSerous AdenocarcinomaUterine Neoplasm Sir Mortimer B. Davis - Jewish General Hospital
Large-scale testing (Phase 3)Ended earlyNCT04159155What this trial is testingVarious Treatments in Serous or p53 Abnormal Endometrial CancerWho this might be right forEndometrial CarcinomaP53 MutationSerous Carcinoma University Health Network, Toronto 11
Large-scale testing (Phase 3)Study completedNCT03285802What this trial is testingTreatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene MutationWho this might be right forUterine Cancer Greater Baltimore Medical Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00506779What this trial is testingGleevec/Taxol for Patients With Uterine Papillary Serous CarcinomaWho this might be right forUterine Cancer M.D. Anderson Cancer Center 17
Early research (Phase 1)Study completedNCT03325634What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine CancerWho this might be right forRecurrent Endometrial Serous AdenocarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+1 more University of Colorado, Denver 15
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00478426What this trial is testingSunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+5 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT04590248What this trial is testingAdavosertib as Treatment for Uterine Serous CarcinomaWho this might be right forUterine Serous Carcinoma AstraZeneca 109
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07832227What this trial is testingImlunestrant/Abemaciclib/Selinexor in Ovarian and EndometrialWho this might be right forLow Grade Ovarian Serous AdenocarcinomaEndometrial Cancer Dana-Farber Cancer Institute 60
Large-scale testing (Phase 3)Study completedNCT00006027What this trial is testingComparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial CancerWho this might be right forEndometrial Cancer Radiation Therapy Oncology Group
Large-scale testing (Phase 3)Study completedNCT00002493What this trial is testingRadiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerWho this might be right forEndometrial CancerPsychosocial Effects of Cancer and Its Treatment Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00025467What this trial is testingThalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00147680What this trial is testingUterine Papillary Serous Cancer (UPSC) TrialWho this might be right forUterine Cancer Queensland Centre for Gynaecological Cancer 30